Assignee
CELMED ONCOLOGY USA INC
CA·8 granted patents·3 pending applications·36 citations·filing 2000–2008
Top patents by PatentIndex Score
11 records- 0180US7419968B1Methods for treating therapy-resistant tumorsCELMED ONCOLOGY USA INC·Filed 2000·Granted Sep 2, 2008·9 cites·4 claims
- 0278US7462605B2Phosphoramidate compounds and methods of useCELMED ONCOLOGY USA INC·Filed 2002·Granted Dec 9, 2008·7 cites·28 claims
- 0378US7163923B2Peptide deformylase activated prodrugsCELMED ONCOLOGY USA INC·Filed 2002·Granted Jan 16, 2007·10 cites·23 claims
- 0478US7138388B2Methods to treat autoimmune and inflammatory conditionsCELMED ONCOLOGY USA INC·Filed 2002·Granted Nov 21, 2006·5 cites·2 claims
- 0573US7601703B2Enzyme catalyzed therapeutic agentsCELMED ONCOLOGY USA INC·Filed 2001·Granted Oct 13, 2009·3 cites·7 claims
- 0673US7465734B2Methods and compositions for overcoming resistance to biologic and chemotherapyCELMED ONCOLOGY USA INC·Filed 2001·Granted Dec 16, 2008·2 cites·21 claims
- 0768US2009069268A1Novel phosphoramidate compounds and methods of useCELMED ONCOLOGY USA INC·Filed 2008·Application pending·0 cites
- 0864US2007213307A1Methods to treat autoimmune and inflammatory conditionsCELMED ONCOLOGY USA INC·Filed 2006·Application pending·0 cites
- 0964US2007155673A1Use of bvdu for inhibiting the growth of hyperproliferative cellsCELMED ONCOLOGY USA INC·Filed 2007·Application pending·0 cites
- 1055US7605144B2Enzyme catalyzed therapeutic compoundsCELMED ONCOLOGY USA INC·Filed 2003·Granted Oct 20, 2009·0 cites·20 claims
- 1146US7001922B2Peptide deformylase activated prodrugsCELMED ONCOLOGY USA INC·Filed 2003·Granted Feb 21, 2006·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when CELMED ONCOLOGY USA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →